These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24930498)

  • 1. The effect of age on the systemic inflammatory response in patients with community-acquired pneumonia.
    van Vught LA; Endeman H; Meijvis SC; Zwinderman AH; Scicluna BP; Biesma DH; van der Poll T
    Clin Microbiol Infect; 2014 Nov; 20(11):1183-8. PubMed ID: 24930498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory response.
    Bordon JM; Fernandez-Botran R; Wiemken TL; Peyrani P; Uriarte SM; Arnold FW; Rodriquez-Hernandez L; Rane MJ; Kelley RR; Binford LE; Uppatla S; Cavallazzi R; Blasi F; Aliberti S; Restrepo MI; Fazeli S; Mathur A; Rahmani M; Ayesu K; Ramirez J
    Infection; 2015 Dec; 43(6):729-38. PubMed ID: 26424683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-acquired pneumonia in older patients: does age influence systemic cytokine levels in community-acquired pneumonia?
    Kelly E; MacRedmond RE; Cullen G; Greene CM; McElvaney NG; O'Neill SJ
    Respirology; 2009 Mar; 14(2):210-6. PubMed ID: 19272082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis.
    Hedlund J
    Scand J Infect Dis Suppl; 1995; 97():1-60. PubMed ID: 8584866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating cytokines as markers of systemic inflammatory response in severe community-acquired pneumonia.
    Igonin AA; Armstrong VW; Shipkova M; Lazareva NB; Kukes VG; Oellerich M
    Clin Biochem; 2004 Mar; 37(3):204-9. PubMed ID: 14972642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of CRB-65 as a prognostic scoring system in adult patients with bacteraemic pneumococcal pneumonia.
    Dwyer R; Hedlund J; Darenberg J; Henriques-Normark B; Naucler P; Runesdotter S; Kalin M
    Scand J Infect Dis; 2011 Jul; 43(6-7):448-55. PubMed ID: 21370939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower incidence of acute respiratory distress syndrome in community-acquired pneumonia patients aged 85 years or older.
    Toba A; Yamazaki M; Mochizuki H; Noguchi T; Tsuda Y; Kawate E; Suzuki Y; Takahashi H
    Respirology; 2010 Feb; 15(2):319-25. PubMed ID: 20070586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response.
    Tejera A; Santolaria F; Diez ML; Alemán-Valls MR; González-Reimers E; Martínez-Riera A; Milena-Abril A
    Cytokine; 2007 Jun; 38(3):117-23. PubMed ID: 17659879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic and bronchoalveolar cytokines as predictors of in-hospital mortality in severe community-acquired pneumonia.
    Lee YL; Chen W; Chen LY; Chen CH; Lin YC; Liang SJ; Shih CM
    J Crit Care; 2010 Mar; 25(1):176.e7-13. PubMed ID: 19592208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-6 and TNF-α serum levels are associated with early death in community-acquired pneumonia patients.
    Bacci MR; Leme RC; Zing NP; Murad N; Adami F; Hinnig PF; Feder D; Chagas AC; Fonseca FL
    Braz J Med Biol Res; 2015 May; 48(5):427-32. PubMed ID: 25714883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: a prospective clinical study.
    Ferrer M; Torres A; Martínez R; Ramírez P; Polverino E; Montull B; Sialer S; Niederman MS; Agusti A; Menéndez R
    Respirology; 2014 Aug; 19(6):929-35. PubMed ID: 24909304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia.
    Thiem U; Niklaus D; Sehlhoff B; Stückle C; Heppner HJ; Endres HG; Pientka L
    Age Ageing; 2009 Nov; 38(6):693-7. PubMed ID: 19729453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and significance of various scores for pneumonia severity in the management of patients with community-acquired pneumonia in China.
    Yang Y; Xu F; Shi LY; Diao R; Cheng YS; Chen XY; Jing JY; Wang XD; Shen HH
    Chin Med J (Engl); 2012 Feb; 125(4):639-45. PubMed ID: 22490488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic cytokine levels in community-acquired pneumonia and their association with disease severity.
    Antunes G; Evans SA; Lordan JL; Frew AJ
    Eur Respir J; 2002 Oct; 20(4):990-5. PubMed ID: 12412694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience.
    Ioachimescu OC; Ioachimescu AG; Iannini PB
    Int J Antimicrob Agents; 2004 Nov; 24(5):485-90. PubMed ID: 15519482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Krueppel-Like Factor 4 Expression in Phagocytes Regulates Early Inflammatory Response and Disease Severity in Pneumococcal Pneumonia.
    Herta T; Bhattacharyya A; Rosolowski M; Conrad C; Gurtner C; Gruber AD; Ahnert P; Gutbier B; Frey D; Suttorp N; Hippenstiel S; Zahlten J
    Front Immunol; 2021; 12():726135. PubMed ID: 34589087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of time on the systemic inflammatory response in pneumococcal pneumonia.
    Calbo E; Alsina M; Rodríguez-Carballeira M; Lite J; Garau J
    Eur Respir J; 2010 Mar; 35(3):614-8. PubMed ID: 19608588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers define the clinical response to dexamethasone in community-acquired pneumonia.
    Remmelts HH; Meijvis SC; Heijligenberg R; Rijkers GT; Oosterheert JJ; Bos WJ; Endeman H; Grutters JC; Hoepelman AI; Biesma DH
    J Infect; 2012 Jul; 65(1):25-31. PubMed ID: 22410382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD.
    Crisafulli E; Menéndez R; Huerta A; Martinez R; Montull B; Clini E; Torres A
    Chest; 2013 Apr; 143(4):1009-1017. PubMed ID: 23187314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [C-reactive protein, leukocyte count and ESR in the assessment of severity of community-acquired pneumonia].
    Bircan A; Kaya O; Gökirmak M; Oztürk O; Sahin U; Akkaya A
    Tuberk Toraks; 2006; 54(1):22-9. PubMed ID: 16615014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.